Skip to Main Content
Advertisement intended for health care professionals
Close
ASH
ASH Home
ASH Store
Advocacy
Education
Meetings
Publications
Research
ASH Clinical News
ASH Image Bank
ASH News Daily
ASH-SAP
Blood Journals
Blood
Blood Advances
Blood Global Hematology
Blood Immunology & Cellular Therapy
Blood Neoplasia
Blood Red Cells & Iron
Blood Vessels, Thrombosis & Hemostasis
Hematology
The Hematologist
International
Blood Chinese Edition
Blood Italian Edition
Blood Latin America Edition
Blood Spanish Edition
Cart
User Tools Dropdown
Cart
Sign In
Search Dropdown Menu
header search
search input
Search input auto suggest
filter your search
All Content
All Journals
Blood Advances
Search
Toggle Menu
Menu
Issues
Current Issue
All Issues
Latest Articles
First Edition
Latest Articles
Guidelines
Collections
Collections
Special Collections
Multimedia
Author Center
Author Guide
Style Guide
Submit
Why Submit to Blood Advances?
About
About Blood Advances
Alerts
Copyright
Editorial Board
Publications Staff
Skip Nav Destination
Current Issue
Volume 9
,
Issue 8
,
April 22 2025
View This Issue
Latest Articles
Taking a break: a therapeutic option for ECD?
Finding the right fit: assessment of fitness in AML
Neutrophil recruitment depends on platelet-derived leukotriene B4
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma
Key role of long-duration cardiac rhythm monitoring in patients with sickle cell disease with atrial hyperexcitability
Paudel BB, Tan S-F, Fox TE, et al. Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes.
Blood Adv
. 2024;8(5):1137-1142.
A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma
Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia
DNMT3A regulates murine megakaryocyte-biased hematopoietic stem cell fate decisions
Advertisement intended for health care professionals
Year in review:
Blood Advances'
ten most read articles published in 2024
17,000 citations
earned in 2023
Acknowledgement of Reviewers 2024
ASH Commitment to Diversity, Equity, and Inclusion in Health Care
Featured Content
Audit of B-cell cancer genes
Fedratinib in 2025 and beyond: indications and future applications
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial
C3 as a predictive and prognostic biomarker in adult hemophagocytic lymphohistiocytosis: a large cohort study in China
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT)
Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
Advertisement intended for health care professionals
close advertisement